Turnstone Biologics Corp.

Ownership Transactions Reported by 16 Insiders

Symbol
TSBX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
9310 Athena Circle, Suite 300, La Jolla, CA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Turnstone Biologics Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William D. Waddill Director Jun 3, 2024
Kanya Rajangam Director Jun 3, 2024
Saryah Azmat Chief Business Officer Oct 16, 2023
Peter Joseph Campisi Jr. Chief Legal Officer Oct 16, 2023
Sammy J. Farah President & CEO, Director Oct 16, 2023
Venkat Ramanan Chief Financial Officer Oct 16, 2023
Patrick Machado Director Jul 20, 2023
Davis Jerel Director, 10%+ Owner Jun 3, 2024
Orbimed Advisors Llc Director, 10%+ Owner Jul 20, 2023
Rishi Gupta Director, 10%+ Owner Jun 3, 2024
Fmr Llc Other* Jan 9, 2024
Stewart Abbot Chief Scientific Officer Oct 16, 2023
Michael F. Burgess Interim Chief Medical Officer, Director Oct 16, 2023
Versant Ventures V, LLC 10%+ Owner Jul 25, 2023
Robert J. Gould Director Jun 3, 2024
Vijay Chiruvolu Int. Chief Technology Officer Jul 20, 2023

Recent Insider Transactions by Companies or Individuals for Turnstone Biologics Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.